01
Life Science Park is the anchor
Changping's ecosystem joins specialised carriers with pharmaceutical companies, research hospitals, diagnostics, clinical researchers, device engineers, CROs and laboratory partners.
Active infrastructureLast reviewed · 26 August 2026
02
AI + healthcare is formal industrial policy
Current measures cover healthcare and multi-omics datasets, specialised biopharma compute, life-science and pharmaceutical models, AI drug discovery, diagnostics, medical devices and synthetic biology.
Current policyLast reviewed · 26 August 2026
03
Policy addresses scientific result → company
The programme includes proof-of-concept, technology transfer and commercialisation routes relevant to research spinouts and scientific IP.
Current policyLast reviewed · 26 August 2026
04
Industrial fit does not remove health-sector regulation
Clinical data, ethics, pharmaceuticals, medical devices, biosafety, IP and research agreements remain separate feasibility layers.
Desk assessmentLast reviewed · 26 August 2026